Effect of BPV1 E2-Mediated Inhibition of E6/E7 Expression in HPV16-Positive Cervical Carcinoma Cells
- 28 February 2001
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 80 (2), 168-175
- https://doi.org/10.1006/gyno.2000.6053
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cellsNature, 1998
- Transactivation of Prothymosin α and c-mycPromoters by Human Papillomavirus Type 16 E6 ProteinVirology, 1997
- Human Papillomaviruses and cervical CancerAdvances in Cancer Research, 1997
- Telomerase activation by the E6 gene product of human papillomavirus type 16Nature, 1996
- The retinoblastoma protein binds to a family of E2F transcription factors.Molecular and Cellular Biology, 1993
- E2F: a Link Between the Rb Tumor Suppressor Protein and Viral OncoproteinsScience, 1992
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Cell, 1990
- Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNAThe Lancet, 1990
- The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene ProductScience, 1989
- In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinomaHuman Pathology, 1986